What is Hardy Diagnostics?
Hardy Diagnostics, established in 1980 and headquartered in Santa Maria, California, is a prominent player in the laboratory and microbiology supplies manufacturing sector. The company specializes in the production of prepared and powdered culture media, essential for the detection of microorganisms. Its long-standing presence and focused product line position it as a key supplier within the life sciences and diagnostics industries.
How much funding has Hardy Diagnostics raised?
Hardy Diagnostics has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Hardy Diagnostics
PPP
Public-Private Partnership
What's next for Hardy Diagnostics?
The substantial enterprise-level funding, highlighted by the recent strategic investment, suggests Hardy Diagnostics is poised for significant expansion and innovation. This capital infusion is likely to fuel advancements in product development, enhance manufacturing capabilities, and potentially broaden market reach. The company's focus on essential microbiology supplies indicates a strategic alignment with ongoing global health and research demands, positioning it for sustained growth and market leadership.
See full Hardy Diagnostics company page
